Biosynex SA (EPA:ALBIO)
0.9780
+0.0540 (5.84%)
Feb 19, 2026, 5:35 PM CET
Biosynex Employees
Biosynex had 454 employees as of June 30, 2025. The number of employees decreased by 22 or -4.62% since the number was reported on December 31, 2024.
Employees
454
Change
-22
Growth
-4.62%
Revenue / Employee
€215,756
Profits / Employee
€156,363
Market Cap
17.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 454 | -22 | -4.62% |
| Dec 31, 2024 | 476 | -93 | -16.34% |
| Dec 31, 2023 | 569 | 202 | 55.04% |
| Dec 31, 2022 | 367 | 107 | 41.15% |
| Dec 31, 2021 | 260 | 68 | 35.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novacyt | 234 |
| Median Technologies | 211 |
| Carmat | 153 |
| Diagnostic Medical Systems | 140 |
| Bluelinea Société Anonyme | 89 |
| Carvolix | 76 |
| Mauna Kea Technologies | 61 |
| Implanet | 46 |